Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Frontiers in Endocrinology
|
December 9, 2022
A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates
Brian Rady, Jianying Liu, Hui Huang, et al.
Molecular and Cellular Biology
|
July 15, 2009
The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis
Shaodong Guo, Kyle D Copps, Xiaocheng Dong, et al.
Cardiovascular Diabetology
|
April 19, 2015
Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats
Xiaoyan Zhou, Chin-hu Huang, Julie Lao, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 17, 2017
Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury
Monicah A Otieno, Jan Snoeys, Wing Lam, et al.
Bioorganic & Medicinal Chemistry
|
October 8, 2013
A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity
Elisabetta Bianchi, Paul E Carrington, Paolo Ingallinella, et al.
Journal of the American Society for Mass Spectrometry
|
February 7, 2014
Quantification of intact and truncated stromal cell-derived factor-1α in circulation by immunoaffinity enrichment and tandem mass spectrometry
Weixun Wang, Bernard K Choi, Wenyu Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 19, 2008
Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2
Erez F Scapa, Alessandro Pocai, Michele K Wu, et al.
Molecular Pharmacology
|
March 25, 2018
GPR40-Mediated G<i>α</i>12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets
Marie-Laure Rives, Brian Rady, Nadia Swanson, et al.
Obesity (Silver Spring, Md.)
|
March 17, 2012
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin
Jennifer R Kosinski, James Hubert, Paul E Carrington, et al.
Analytical Biochemistry
|
September 27, 2016
Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo
Jenson Qi, Wensheng Lang, Margery A Connelly, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Frontiers in Endocrinology
|
December 9, 2022
A FFAR1 full agonist restores islet function in models of impaired glucose-stimulated insulin secretion and diabetic non-human primates
Brian Rady, Jianying Liu, Hui Huang, et al.
Molecular and Cellular Biology
|
July 15, 2009
The Irs1 branch of the insulin signaling cascade plays a dominant role in hepatic nutrient homeostasis
Shaodong Guo, Kyle D Copps, Xiaocheng Dong, et al.
Cardiovascular Diabetology
|
April 19, 2015
Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats
Xiaoyan Zhou, Chin-hu Huang, Julie Lao, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 17, 2017
Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury
Monicah A Otieno, Jan Snoeys, Wing Lam, et al.
Bioorganic & Medicinal Chemistry
|
October 8, 2013
A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity
Elisabetta Bianchi, Paul E Carrington, Paolo Ingallinella, et al.
Journal of the American Society for Mass Spectrometry
|
February 7, 2014
Quantification of intact and truncated stromal cell-derived factor-1α in circulation by immunoaffinity enrichment and tandem mass spectrometry
Weixun Wang, Bernard K Choi, Wenyu Li, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 19, 2008
Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2
Erez F Scapa, Alessandro Pocai, Michele K Wu, et al.
Molecular Pharmacology
|
March 25, 2018
GPR40-Mediated G<i>α</i>12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets
Marie-Laure Rives, Brian Rady, Nadia Swanson, et al.
Obesity (Silver Spring, Md.)
|
March 17, 2012
The glucagon receptor is involved in mediating the body weight-lowering effects of oxyntomodulin
Jennifer R Kosinski, James Hubert, Paul E Carrington, et al.
Analytical Biochemistry
|
September 27, 2016
Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo
Jenson Qi, Wensheng Lang, Margery A Connelly, et al.
Page
of 7